Information AboutVaccine |
| CATEGORIES ABOUT VACCINE | |
| virology | |
| vaccination | |
| infectious diseases | |
|
Vaccines against cancer are also being investigated; see Cancer Vaccine . In this case, the antigenic preparation is derived from the cancer cell. There is also research on an HIV Vaccine . ORIGIN OF VACCINES Smallpox was the first disease people tried to prevent by purposely inoculating themselves with other types of infections. Inoculation is believed to have started in India or China before 200 BC. Physicians in China immunized patients by picking off pieces from drying Pustule s of a person suffering from a mild case of smallpox, grinding the scales to a powdery substance, and then inserting the powder into the person's nose in order for them to be immunized. In 1718 , Lady Mary Wortley Montague reported that the Turks have a habit of deliberately inoculating themselves with fluid taken from mild cases of smallpox. Lady Montague inoculated her own children in this manner. In 1796 , during the heyday of the Smallpox virus in Europe, an English country doctor, Edward Jenner , observed that Milkmaid s would sometimes become infected with Cowpox through their interactions with dairy cows' udders. Cowpox is a mild relative of the deadly smallpox virus. Building on the foundational practice of inoculation, Jenner took infectious fluid from the hand of milkmaid Sarah Nelmes. He inserted this fluid, by scratching or injection, into the arm of a healthy local eight year old boy, James Phipps. Phipps then showed symptoms of cowpox infection. Forty-eight days later, after Phipps had fully recovered from cowpox, Jenner injected some smallpox-infected matter into Phipps, but Phipps did not later show signs of smallpox infection. TYPES OF VACCINES Vaccines may be living, weakened strains of Virus es or Bacteria which intentionally give rise to inapparent-to-trivial infections. Vaccines may also be killed or inactivated organisms or purified products derived from them. There are three types of traditional vaccines {Link without Title} :
The live Tuberculosis vaccine is not the Contagious TB strain, but a related strain called " BCG "; it is used in the United States very infrequently. A number of innovative vaccines are also in development and also in use:
DEVELOPING IMMUNITY The immune system recognizes vaccine agents as foreign, destroys them, and 'remembers' them. When the Virulent version of an agent comes along, the immune system is thus prepared to respond, by (1) neutralizing the target agent before it can enter cells, and (2) by recognizing and destroying infected cells before that agent can multiply to vast numbers. Vaccines have contributed to the eradication of Smallpox , one of the most contagious and deadly diseases known to man. Other diseases such as rubella, Polio , measles, mumps, Chickenpox , and Typhoid are nowhere near as common as they were just a hundred years ago. As long as the vast majority of people are vaccinated, it is much more difficult for an outbreak of disease to occur, let alone spread. This effect is called Herd Immunity . CONTROVERSY SURROUNDING THE USE OF VACCINES Main article: Vaccine Controversy Opposition to vaccination, from a wide array of vaccine critics, has existed since the earliest vaccination campaigns: {Link without Title} . A number of vaccines, including those given to very young children, have contained Thimerosal , a preservative that metabolizes into ethylmercury. It has been used in some Influenza , DTP ( Diphtheria , Tetanus and Pertussis ) vaccine formulations. Since 1997 , use of thimerosal has been gradually diminishing in western industrialized countries after recommendations by medical authorities, but trace amounts of thimerosal remain in many vaccines and in some vaccines, thimerosal has not yet been phased out despite recommendations. Some states in USA have enacted laws banning the use of thimerosal in childhood vaccines. In the late 1990s, controversy over vaccines escalated in both the US and the reported that evidence "favors rejection" of any link between vaccines containing thimerosal, or MMR, and the development of autism {Link without Title} . In 2004 and 2005 , England and Wales experienced an increase in the incidence of mumps infections among adolescents and young adults. This outbreak was independent of the decline in uptake of MMR following the alleged misinformation generated by Wakefield's study (the age group affected were too old to have been due to receive the routine MMR immunisations around the time this article was published). The increase in cases of mumps in the UK instead relates to the age group affected being too young to have contracted natural mumps as a child (an effect of herd immunity due to the decline in mumps that followed the introduction of the MMR vaccine), but too old to have received the MMR vaccine. Individuals in this age group therefore had no immunity, either natural or vaccine induced, against mumps, and were susceptible to the re-emergence of this disease. {Link without Title} {Link without Title} . This and similar examples indicate the importance of 1.careful modelling to anticipate the impact that an immunisation campaign will have on the epidemiology of the disease in the medium to long term 2. ongoing surveillance for the relevant disease following introduction of a new vaccine and 3. maintaining high immunisation rates, even when a disease has become rare. There is opposition to vaccination (of any type) from some sectors of the community, particularly those who favour 'alternative' health care. Often this opposition is not based on specific data or details but rather a general leaning against conventional medicine and science. Naturopaths and other alternative health care practitioners sometimes offer their own, alternative treatments to conventional vaccination. In Australia , a massive increase in vaccination rates was observed when the federal government made certain benefits (such as the universal 'Family Allowance' welfare payments for parents of children) dependent on vaccination. As well, children were not allowed into school unless vaccination had been done. Parents were still able to refuse to vaccinate their children, but it involved completion of a statutory declaration after discussion with a doctor, and other bureaucracy. It became easier and cheaper to vaccinate one's children than not to. When faced with the annoyance, many more casual objectors simply gave in. Potential for adverse side effects in general Some refuse to immunize themselves or their children, because they believe certain vaccines' adverse side effects outweigh their benefits. A variation of this reasoning is that not enough is known of the adverse effects to determine whether the potential benefits make the risks worthwhile. Since most people are vaccinated against contagious and potentially fatal diseases, the chances of someone who is not vaccinated becoming ill is a good deal smaller than it might be if their opinion was held by more people. Thus they acquire some of the benefits of vaccines, through herd immunity, without assuming the risks those who choose to vaccinate do. Advocates of recommended routine vaccination argue that side effects of most approved vaccines are either far less serious than actually catching the disease, or are very rare, and argue that the calculus of risk/benefit ratio should be based on benefit to humanity rather than simply on the benefit to the immunized individual. The main risk of rubella, for example, is to the Fetus es of Pregnant women, but this risk can be effectively reduced by the Immunization of children to prevent transmission to pregnant women. Efficacy of vaccines Vaccines do ''not'' guarantee complete protection from a disease. Even after a vaccination, there is still a possibility that a vaccinated person may get the disease. Sometimes this is because the host's immune system simply doesn't respond adequately or at all. This is known in medical jargon as a 'low titre of antibodies'. This may be due to a lowered immunity in general (diabetes, steroid use, HIV infection) or just bad luck (the host's immune system does not have a B-cell capable of generating antibodies to that antigen). Even if the host develops antibodies, the human immune system is not perfect. Some germs can mutate (the common cold and influenza viruses are highly efficient at this), and in any case the immune system might still not be able to defeat the infection. Adjuvant s are typically used to boost immune response. The efficacy or performance of the vaccine is dependent on a number of factors:
In cases where a vaccinated individual does develop the disease vaccinated against, the disease is likely to be milder than without vaccination. ECONOMICS OF VACCINE DEVELOPMENT One challenge in vaccine development is economic: many of the diseases most demanding a vaccine, including HIV , Malaria and tuberculosis, exist principally in poor countries. Although some contend pharmaceutical firms and biotech companies have little incentive to develop vaccines for these diseases, because there is little revenue potential, the number of vaccines actually administered has risen dramatically in recent decades. This increase, particularly in the number of different vaccines administered to children before entry into schools may be due to government mandates, rather than economic incentive. Most vaccine development to date has relied on 'push' funding by government and non-profit organizations, of government agencies, universities and non-profit organizations. Many researchers and policymakers are calling for a different approach, using 'pull' mechanisms to motivate industry. Mechanisms such as prizes, tax credits, or Advance Market Commitments could ensure a financial return to firms that successfully developed an HIV vaccine. If the policy were well-designed, it might also ensure people have access to a vaccine if and when it is developed. PRESERVATIVES In order to extend shelf life and reduce production and storage costs, Thimerosal , a Mercury -containing organic compound, was used routinely until recent years as a preservative. Thimerosal is gradually being phased out in the U.S. (it has been phased out in other countries, e.g. Denmark in 1992), but may be used in stages of manufacture. Parents wishing to avoid this preservative, most common in multi-dose containers of influenza vaccine, may specifically ask for thimerosal-free alternatives that contain only trace amounts. SEE ALSO REFERENCES
http://www.coldcure.com/html/smallpox.html on timeline of vaccine history Vaccine proponent views
Vaccine safety critical views
|
|
|